Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model

International Journal of Pharmaceutics

Volumn 441, Issue 1-2, 2013, Pages 285-290

  Dong, Ji ^a   Jiang, Dinghua ^a   Wang, Zhen ^a   Wu, Guizhong ^a   Miao, Liyan ^a   Huang, Lixin ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Celecoxib; Combination; Hyaluronate; Intra articular injection; Liposome; Osteoarthritis

Indexed keywords

CELECOXIB; HYALURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE DEGENERATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; DRUG RELEASE; EXPERIMENTAL RABBIT; FEMUR CONDYLE; HISTOPATHOLOGY; LIPOSOMAL DELIVERY; MONOTHERAPY; NANOENCAPSULATION; NONHUMAN; OSTEOARTHRITIS; PAIN ASSESSMENT; PARTICLE SIZE; PRIORITY JOURNAL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; CYCLOOXYGENASE 2 INHIBITORS; GELS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; LIPOSOMES; OSTEOARTHRITIS, KNEE; PAIN; PYRAZOLES; RABBITS; SULFONAMIDES; VISCOSUPPLEMENTS;

EID: 84872827598     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.11.031     Document Type: Article

References (24)

1. A.D. Bangham, M.M. Standish, and J.C. Watkins Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 13 1965 238 252
2. M.H. Bonanomi, M. Velvart, M. Stimpel, K.M. Roos, K. Fehr, and H.G. Weder Studies of pharmacokinetics and therapeutic effects of glucocorticoids entrapped in liposomes after intraarticular application in healthy rabbits and in rabbits with antigen-induced arthritis Rheumatol. Int. 7 1987 203 212
3. C. Buckland-Wright Subchondral bone changes in hand and knee osteoarthritis detected by radiography Osteoarthritis Cartilage 12 Suppl. (A) 2004 S10 S19
4. J.A. Champion, A. Walker, and S. Mitragotri Role of particle size in phagocytosis of polymeric microspheres Pharm. Res. 25 2008 1815 1821
5. D. Clemett, and K.L. Goa Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain Drugs 59 2000 957 980
6. M. de Silva, B.L. Hazleman, D.P. Thomas, and P. Wraight Liposomes in arthritis: a new approach Lancet 1 1979 1320 1322
7. S.H. Edwards, M.A. Cake, G. Spoelstra, and R.A. Read Biodistribution and clearance of intra-articular liposomes in a large animal model using a radiographic marker J. Liposome Res. 17 2007 249 261
8. J.V. Forrester, and E.A. Balazs Inhibition of phagocytosis by high molecular weight hyaluronate Immunology 40 1980 435 446
9. N. Gerwin, C. Hops, and A. Lucke Intraarticular drug delivery in osteoarthritis Adv. Drug Deliv. Rev. 58 2006 226 242
10. H.A. Greisen, B.A. Summers, and G. Lust Ultrastructure of the articular cartilage and synovium in the early stages of degenerative joint disease in canine hip joints Am. J. Vet. Res. 43 1982 1963 1971
11. L. Haywood, D.F. McWilliams, C.I. Pearson, S.E. Gill, A. Ganesan, D. Wilson, and D.A. Walsh Inflammation and angiogenesis in osteoarthritis Arthritis Rheum. 48 2003 2173 2177
12. K. Hirota, T. Hasegawa, H. Hinata, F. Ito, H. Inagawa, C. Kochi, G. Soma, K. Makino, and H. Terada Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages J. Control. Release 119 2007 69 76
13. A. Hulth, L. Lindberg, and H. Telhag Experimental osteoarthritis in rabbits preliminary report Acta Orthop. Scand. 41 1970 522 530
14. T. Kikuchi, H. Yamada, and M. Shimmei Effect of high molecular weight hyaluronan on cartilage degeneration in a rabbit model of osteoarthritis Osteoarthritis Cartilage 4 1996 99 110
15. J.R. Levick A method for estimating macromolecular reflection by human synovium, using measurements of intra-articular half lives Ann. Rheum. Dis. 57 1998 339 344
16. M. Mihara, S. Higo, Y. Uchiyama, K. Tanabe, and K. Saito Different effects of high molecular weight sodium hyaluronate and NSAID on the progression of the cartilage degeneration in rabbit OA model Osteoarthritis Cartilage 15 2007 543 549
17. L.W. Moreland Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action Arthritis Res. Ther. 5 2003 54 67
18. I. Pasquali-Ronchetti, L. Frizziero, D. Guerra, M. Baccarani-Contri, M.C. Focherini, A. Georgountzos, D. Vincenzi, F. Cicchetti, A. Perbellini, and E. Govoni Aging of the human synovium: an in vivo and ex vivo morphological study Semin. Arthritis Rheum. 21 1992 400 414
19. R.R. Patlolla, M. Chougule, A.R. Patel, T. Jackson, P.N. Tata, and M. Singh Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers J. Control. Release 144 2010 233 241
20. S.K. Paulson, M.B. Vaughn, S.M. Jessen, Y. Lawal, C.J. Gresk, B. Yan, T.J. Maziasz, C.S. Cook, and A. Karim Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption J. Pharmacol. Exp. Ther. 297 2001 638 645
21. S.D. Solomon, J.J. McMurray, M.A. Pfeffer, J. Wittes, R. Fowler, P. Finn, W.F. Anderson, A. Zauber, E. Hawk, and M. Bertagnolli Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention N. Engl. J. Med. 352 2005 1071 1080
22. S.F. Sun, Y.J. Chou, C.W. Hsu, C.W. Hwang, P.T. Hsu, J.L. Wang, Y.W. Hsu, and M.C. Chou Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study Osteoarthritis Cartilage 14 2006 867 874
23. S.M. Wigginton, B.C. Chu, M.H. Weisman, and S.B. Howell Methotrexate pharmacokinetics after intraarticular injection in patients with rheumatoid arthritis Arthritis Rheum. 23 1980 119 122
24. M. Wong, P. Chowienczyk, and B. Kirkham Cardiovascular issues of COX-2 inhibitors and NSAIDs Aust. Fam. Physician 34 2005 945 948